Charles Schwab’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-207,124
| Closed | -$29M | – | 3225 |
|
|
2018
Q4 | $29M | Buy |
207,124
+346
| +0.2% | +$48.5K | 0.02% | 743 |
|
|
2018
Q3 | $35.3M | Buy |
206,778
+77,762
| +60% | +$13.3M | 0.02% | 733 |
|
|
2018
Q2 | $22.4M | Buy |
129,016
+18,041
| +16% | +$3.13M | 0.02% | 997 |
|
|
2018
Q1 | $12.8M | Buy |
110,975
+2,960
| +3% | +$342K | 0.01% | 1319 |
|
|
2017
Q4 | $9.09M | Buy |
108,015
+2,274
| +2% | +$191K | 0.01% | 1539 |
|
|
2017
Q3 | $9.74M | Buy |
105,741
+24,025
| +29% | +$2.21M | 0.01% | 1452 |
|
|
2017
Q2 | $6.55M | Buy |
81,716
+7,824
| +11% | +$627K | 0.01% | 1647 |
|
|
2017
Q1 | $3.11M | Buy |
73,892
+30,533
| +70% | +$1.29M | ﹤0.01% | 2006 |
|
|
2016
Q4 | $1.39M | Buy |
43,359
+2,310
| +6% | +$74.2K | ﹤0.01% | 2317 |
|
|
2016
Q3 | $1.08M | Buy |
41,049
+20,449
| +99% | +$536K | ﹤0.01% | 2392 |
|
|
2016
Q2 | $478K | Buy |
20,600
+7,400
| +56% | +$172K | ﹤0.01% | 2600 |
|
|
2016
Q1 | $361K | Hold |
13,200
| – | – | ﹤0.01% | 2712 |
|
|
2015
Q4 | $376K | Buy |
+13,200
| New | +$376K | ﹤0.01% | 2769 |
|